Healthcare Contract Research Outsourcing Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Chapter 1       Executive Summary

Chapter 2       Global Healthcare Contract Research Outsourcing Market: An Overview

2.1          Report Description and Research Scope

2.2       Research Methodology

2.2.1      Primary Research

2.2.2      Secondary Research and Internal Data Modeling

2.3       Analyst Credentials

Chapter 3       Major Players of the Global Healthcare Contract Research Outsourcing Market

3.1            Overview

3.2            Present and Forecast Competitive Scenario (2018 Vs 2025)

3.3            Global Healthcare Contract Research Outsourcing Market: Company Share Analysis

Chapter 4       Market Outline

4.1       Market Trend, Outlook and Forecast

4.2          Market Dynamics

4.2.1      Drivers

4.2.1.1  Impact Analysis

4.2.2      Restraints

4.2.2.1  Impact Analysis

4.2.3      Opportunities

4.3          Porter’s Five Forces Analysis

Chapter 5       Market by Service Segments: Size and Forecast, 2016 – 2025

5.1          Overview

5.2          Regulatory Service

5.2.1      Current Trend and Analysis

5.2.2      Market Size and Forecast

5.3          Medical Writing

5.3.1      Current Trend and Analysis

5.3.2      Market Size and Forecast

5.4          Pharmacovigilance

5.4.1      Current Trend and Analysis

5.4.2      Market Size and Forecast

5.5          Site Management Protocol

5.5.1      Current Trend and Analysis

5.5.2      Market Size and Forecast

5.6          Clinical Trial Service

5.6.1      Current Trend and Analysis

5.6.2      Market Size and Forecast

5.7          Clinical Data Management & Biometrics

5.7.1      Current Trend and Analysis

5.7.2      Market Size and Forecast

5.8          Other Services

5.8.1      Current Trend and Analysis

5.8.2      Market Size and Forecast

Chapter 6 Market by Therapeutic Area: Market Size and Forecast, 2016 – 2025

6.1 Overview

6.2 Respiratory

6.2.1      Current Trend and Analysis

6.2.2      Market Size and Forecast

6.3 Infectious Diseases

6.3.1      Current Trend and Analysis

6.3.2      Market Size and Forecast

6.4 Oncology/Hematology

6.4.1      Current Trend and Analysis

6.4.2      Market Size and Forecast

6.5 Immunology

6.5.1      Current Trend and Analysis

6.5.2      Market Size and Forecast

6.6 Rare Diseases

6.6.1      Current Trend and Analysis

6.6.2      Market Size and Forecast

6.7 CNS

6.7.1      Current Trend and Analysis

6.7.2      Market Size and Forecast

6.8 CV/Metabolic

6.8.1      Current Trend and Analysis

6.8.2      Market Size and Forecast

6.9 Medical Devices

6.9.1      Current Trend and Analysis

6.9.2      Market Size and Forecast

6.10    Other Therapeutic Areas

6.10.1   Current Trend and Analysis

6.10.2   Market Size and Forecast

Chapter 7 Market by End User: Market Size and Forecast, 2016 – 2025

7.1  Overview

7.2  Biotechnology Companies

7.2.1      Current Trend and Analysis

7.2.2      Market Size and Forecast

7.3  MedicalDevice Companies

7.3.1      Current Trend and Analysis

7.3.2      Market Size and Forecast

7.4  Pharmaceutical Companies

7.4.1      Current Trend and Analysis

7.4.2      Market Size and Forecast

7.5  Academic institutes & government organizations

7.5.1      Current Trend and Analysis

7.5.2      Market Size and Forecast

Chapter 8 Market by Geography: Market Size and Forecast, 2016 – 2025

8.1  Overview

8.2  North America

8.2.1      Current Trend and Analysis

8.2.2      Market Size and Forecast

8.2.3      Regional Market Dynamics

8.2.3.1      Drivers

8.2.3.2      Restraints

8.2.3.3      Opportunities

8.2.4      U.S.

8.2.4.1      Market Size and Forecast

8.2.5      Canada

8.2.5.1      Market Size and Forecast

8.3  Europe

8.3.1      Current Trend and Analysis

8.3.2      Market Size and Forecast

8.3.3      Regional Market Dynamics

8.3.3.1      Drivers

8.3.3.2      Restraints

8.3.3.3      Opportunities

8.3.4      U.K.

8.3.4.1      Market Size and Forecast

8.3.5      Italy

8.3.5.1      Market Size and Forecast

8.3.6      France

8.3.6.1      Market Size and Forecast

8.3.7      Spain

8.3.7.1      Market Size and Forecast

8.3.8      Rest of Europe

8.3.8.1      Market Size and Forecast

8.4  Asia-Pacific

8.4.1      Current Trend and Analysis

8.4.2      Market Size and Forecast

8.4.3      Regional Market Dynamics

8.4.3.1      Drivers

8.4.3.2      Restraints

8.4.3.3      Opportunities

8.4.4      China

8.4.4.1      Market Size and Forecast

8.4.5      India

8.4.5.1      Market Size and Forecast

8.4.6      Japan

8.4.6.1      Market Size and Forecast

8.4.7      Rest of Asia-Pacific

8.4.7.1      Market Size and Forecast

8.5  Rest of the World (RoW)

8.5.1      Current Trend and Analysis

8.5.2      Market Size and Forecast

8.5.3      Regional Market Dynamics

8.5.3.1      Drivers

8.5.3.2      Restraints

8.5.3.3      Opportunities

8.5.4      South America

8.5.4.1      Market Size and Forecast

8.5.5      Middle East

8.5.5.1      Market Size and Forecast

8.5.6      Africa

8.5.6.1      Market Size and Forecast

Chapter 9   Company Profiles

9.1  Charles River

9.2  Laboratory Corporation of America Holdings

9.3  IQVIA

9.4  Medpace

9.5  Pharmaceutical Product Development, LLC

9.6  Syneos Health

9.7  PAREXEL International Corporation

9.8  ICON plc

9.9  PRA Health Sciences

9.10 Envigo